Skip to content
2000
image of Assessing Alzheimer’s Disease Risk Among Latina/o/x Older Adults: A CART Analysis

Abstract

Introduction/Objective

Alzheimer's Disease (AD) presents a significant public health challenge in the U.S., with Latina/o/x elders being disproportionately affected. This study examines the key risk factors associated with AD in this population.

Methods

We analyzed data from the National Alzheimer's Coordinating Center (2017), focusing on 9,801 Latina/o/x older adults (32.7% males and 67.3% females). Statistical analyses conducted included Chi-square tests, t-tests, and Classification and Regression Tree (CART) analysis, which was used as the main statistical tool.

Results

The CART model, trained on 70% of the sample and tested on the remaining 30% ( = 9,801), identified seven terminal nodes and selected seven key predictors from 16 candidate variables. The model demonstrated modest discriminative ability (AUC = 0.68 for both training and test sets; misclassification error ≈ 36%). Sensitivity was 75%, while specificity was 55% in the test set. The most important predictors included age, education, smoking history, BMI, hypertension, and use of antidepressant or antipsychotic medications. A critical threshold emerged at < 5.5 years of education, which, in interaction with age and smoking, was associated with notably increased AD risk.

Conclusion

This study emphasizes the crucial role of sociodemographic factors-particularly gender, age, and education-in determining AD risk among Latina/o/x elders. CART analysis identified key thresholds for age and education levels impacting AD risk. The findings suggest the need for targeted interventions and policies, with a focus on education and lifestyle factors, to mitigate AD risk in this vulnerable population.

Loading

Article metrics loading...

/content/journals/car/10.2174/0115672050413808250930051731
2025-10-21
2026-02-27
Loading full text...

Full text loading...

References

  1. Alzheimer’s disease. 2024 Available from: https://www.cdc.gov/aging/aginginfo/alzheimers.htm
  2. Fitten L.J. Ortiz F. Pontón M. Frequency of Alzheimer’s disease and other dementias in a community outreach sample of Hispanics. J. Am. Geriatr. Soc. 2001 49 10 1301 1308 10.1046/j.1532‑5415.2001.49257.x 11890488
    [Google Scholar]
  3. Earlier diagnosis. 2025 Available from: https://www. alz.org/alzheimers-dementia/research_progress/earlier-diagnosis
  4. Norton S. Matthews F.E. Barnes D.E. Yaffe K. Brayne C. Potential for primary prevention of Alzheimer’s disease: An analysis of population-based data. Lancet Neurol. 2014 13 8 788 794 10.1016/S1474‑4422(14)70136‑X 25030513
    [Google Scholar]
  5. Sheladia S. Reddy P.H. Age-related chronic diseases and Alzheimer’s disease in Texas: A Hispanic focused study. J. Alzheimers Dis. Rep. 2021 5 1 121 133 10.3233/ADR‑200277 33782665
    [Google Scholar]
  6. Barnes D.E. Yaffe K. The projected effect of risk factor reduction on Alzheimer’s disease prevalence. Lancet Neurol. 2011 10 9 819 828 10.1016/S1474‑4422(11)70072‑2 21775213
    [Google Scholar]
  7. Manly J.J. Glymour M.M. What the Aducanumab approval reveals about Alzheimer disease research. JAMA Neurol. 2021 78 11 1305 1306 10.1001/jamaneurol.2021.3404 34605885
    [Google Scholar]
  8. Tahami Monfared A.A. Byrnes M.J. White L.A. Zhang Q. Alzheimer’s Disease: Epidemiology and clinical progression. Neurol. Ther. 2022 11 2 553 569 10.1007/s40120‑022‑00338‑8 35286590
    [Google Scholar]
  9. Alzheimer’s disease and related dementias (AD/ADRD) health disparities research framework. 2022 Available from: https://www.nia.nih.gov/research/milestones/epidemiology-population-studies/health-equity-identify-risk-factors-across
  10. Studies explore Alzheimer’s risk factors, biomarkers in Latinos. 2018 Available from: https://www.nia.nih.gov/news/studies-explore-alzheimers-risk-factors-biomarkers-latinos
  11. Avila-Rieger J.F. Intersectionality between sex/gender and race/ethnicity on cognitive trajectories and development of Alzheimer’s disease. [Doctoral dissertation The University of New Mexico 2020
    [Google Scholar]
  12. Huang C.C. Chung C.M. Leu H.B. Lin L.Y. Chiu C.C. Hsu C.Y. Chiang C.H. Huang P.H. Chen T.J. Lin S.J. Chen J.W. Chan W.L. Diabetes mellitus and the risk of Alzheimer’s disease: A nationwide population-based study. PLoS One 2014 9 1 87095 10.1371/journal.pone.0087095 24489845
    [Google Scholar]
  13. Mielke M.M. Aggarwal N.T. Vila-Castelar C. Agarwal P. Arenaza-Urquijo E.M. Brett B. Brugulat-Serrat A. DuBose L.E. Eikelboom W.S. Flatt J. Foldi N.S. Franzen S. Gilsanz P. Li W. McManus A.J. van Lent D.M. Milani S.A. Shaaban C.E. Stites S.D. Sundermann E. Suryadevara V. Trani J.F. Turner A.D. Vonk J.M.J. Quiroz Y.T. Babulal G.M. Consideration of sex and gender in Alzheimer’s disease and related disorders from a global perspective. Alzheimers Dement. 2022 18 12 2707 2724 10.1002/alz.12662 35394117
    [Google Scholar]
  14. Lleó A. Suárez-Calvet M. Race and Alzheimer disease biomarkers. Neurol. Genet. 2021 7 2 574 10.1212/NXG.0000000000000574 33688581
    [Google Scholar]
  15. Weiner M.F. Perspective on race and ethnicity in Alzheimer’s disease research. Alzheimers Dement. 2008 4 4 233 238 10.1016/j.jalz.2007.10.016 18631972
    [Google Scholar]
  16. Wada M. Noda Y. Shinagawa S. Chung J.K. Sawada K. Ogyu K. Tarumi R. Tsugawa S. Miyazaki T. Yamagata B. Graff-Guerrero A. Mimura M. Nakajima S. Effect of education on Alzheimer’s disease-related neuroimaging biomarkers in healthy controls, and participants with mild cognitive impairment and Alzheimer’s disease: A cross-sectional study. J. Alzheimers Dis. 2018 63 2 861 869 10.3233/JAD‑171168 29689728
    [Google Scholar]
  17. Sattler C. Toro P. Schönknecht P. Schröder J. Cognitive activity, education and socioeconomic status as preventive factors for mild cognitive impairment and Alzheimer’s disease. Psychiatry Res. 2012 196 1 90 95 10.1016/j.psychres.2011.11.012 22390831
    [Google Scholar]
  18. Lennon M.J. Koncz R. Sachdev P.S. Hypertension and Alzheimer’s disease: Is the picture any clearer? Curr. Opin. Psychiatry 2021 34 2 142 148 10.1097/YCO.0000000000000684 33395097
    [Google Scholar]
  19. Livingston G. Huntley J. Sommerlad A. Ames D. Ballard C. Banerjee S. Brayne C. Burns A. Cohen-Mansfield J. Cooper C. Costafreda S.G. Dias A. Fox N. Gitlin L.N. Howard R. Kales H.C. Kivimäki M. Larson E.B. Ogunniyi A. Orgeta V. Ritchie K. Rockwood K. Sampson E.L. Samus Q. Schneider L.S. Selbæk G. Teri L. Mukadam N. Dementia prevention, intervention, and care: 2020 report of the Lancet Commission. Lancet 2020 396 10248 413 446 10.1016/S0140‑6736(20)30367‑6 32738937
    [Google Scholar]
  20. Torres E.R.S. Rebeck G.W. Nuriel T. Editorial: APOE4-associated heterogeneity in the pathogenesis of Alzheimer’s disease. Front. Aging Neurosci. 2024 16 1509307 10.3389/fnagi.2024.1509307 39629475
    [Google Scholar]
  21. Puranen A. Taipale H. Koponen M. Tanskanen A. Tolppanen A.M. Tiihonen J. Hartikainen S. Incidence of antidepressant use in community-dwelling persons with and without Alzheimer’s disease: 13-year follow-up. Int. J. Geriatr. Psychiatry 2017 32 1 94 101 10.1002/gps.4450 26924266
    [Google Scholar]
  22. Census Bureau releases new educational attainment data. 2022 Available from: https://www.census.gov/newsroom/press-releases/2022/educational-attainment.html
  23. Liu Y. Julkunen V. Paajanen T. Westman E. Wahlund L.O. Aitken A. Sobow T. Mecocci P. Tsolaki M. Vellas B. Muehlboeck S. Spenger C. Lovestone S. Simmons A. Soininen H. Education increases reserve against Alzheimer’s disease—Evidence from structural MRI analysis. Neuroradiology 2012 54 9 929 938 10.1007/s00234‑012‑1005‑0 22246242
    [Google Scholar]
  24. Sando S.B. Melquist S. Cannon A. Hutton M. Sletvold O. Saltvedt I. White L.R. Lydersen S. Aasly J. Risk-reducing effect of education in Alzheimer’s disease. Int. J. Geriatr. Psychiatry 2008 23 11 1156 1162 10.1002/gps.2043 18484674
    [Google Scholar]
  25. Wu M. Zhai Y. Liang X. Chen W. Lin R. Ma L. Huang Y. Zhao D. Liang Y. Zhao W. Fang J. Fang S. Chen Y. Wang Q. Li W. Connecting the dots between hypercholesterolemia and Alzheimer’s disease: A potential mechanism based on 27-Hydroxycholesterol. Front. Neurosci. 2022 16 842814 10.3389/fnins.2022.842814 35464321
    [Google Scholar]
  26. Yao Q. Jiang K. Lin F. Zhu T. Khan N.H. Jiang E. Pathophysiological association of Alzheimer’s disease and hypertension: A clinical concern for elderly population. Clin. Interv. Aging 2023 18 713 728 10.2147/CIA.S400527 37181536
    [Google Scholar]
  27. Tifratène K. Manera V. Fabre R. Gros A. Thümmler S. Pradier C. Robert P. David R. Antipsychotic prescribing for Alzheimer’s disease and related disorders in specialized settings from 2010 to 2014 in France: A repeated cross-sectional study. Alzheimers Res. Ther. 2017 9 1 34 10.1186/s13195‑017‑0256‑8 28446209
    [Google Scholar]
  28. Shieh J.C.C. Huang P.T. Lin Y.F. Alzheimer’s disease and diabetes: Insulin signaling as the bridge linking two pathologies. Mol. Neurobiol. 2020 57 4 1966 1977 10.1007/s12035‑019‑01858‑5 31900863
    [Google Scholar]
  29. Moslimani M. Lopez M.H. Noe-Busteemante L. 11 facts about Hispanic origin groups in the U.S. 2023 Available from: https://www.pewresearch.org/short-reads/2023/08/16/11-facts-about-hispanic-origin-groups-in-the-us/
/content/journals/car/10.2174/0115672050413808250930051731
Loading
/content/journals/car/10.2174/0115672050413808250930051731
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test